- male
- 32 Years
- 22/01/2025
I'm 32 and dealing with anxiety and hypertension. I've been diagnosed with mild concentric left ventricular hypertrophy after a 2D echo. My doctor mentioned taking a TMT and prescribed me TelmaCT 4012.5, Inderal 10, and Rosuvastatin 20. Do you think I should go ahead with the TMT? I'm feeling a bit worried about all this.
Answered by 1 Apollo Doctors
Since you are already diagnosed with mild concentric left ventricular hypertrophy, it is important to follow your doctor's advice and go for the TMT (Treadmill Stress Test) as suggested. This test will help assess your heart's response to physical stress and evaluate any possible blockages in the arteries.
Dr. Mubarak Suggests...
Consult a Cardiologist
Answered 04/07/2025
0
0

More Cardiology Health Queries
View allCan I take Naturolax with my Rosuvas F10 at night? My cholesterol levels have been high, so I've been on Rosuvas for about a month now. I don't have hypertension or diabetes, just trying to manage my cholesterol. Would mixing these two be okay?
can be taken..
Answered by 1 Apollo Doctors
I've just had a 2D echo and it mentioned mild concentric LVH. I'm curious about what that really means. Should I be worried about it? Could you explain it in a way that's easy to understand?
left venticular hypertrophy
Answered by 1 Apollo Doctors
We've been giving our mom Axcer 90 mg along with other meds like Atocor, Ecospirin, and stuff for her thyroid for about two months now. We're wondering if we could stop the Axcer since we've been on it for a while and honestly, it's just really expensive. We can't keep up with the cost. Is there a cheaper alternative that works just as well? Would love to hear your advice on this.
no do not stop it without doctors advice,as you say you are having affordability issues,ask your doctor for alternate medication
Answered by 1 Apollo Doctors
Disclaimer: Answers on Apollo 247 are not intended to replace your doctor advice. Always seek help of a professional doctor in case of an medical emergency or ailment.





